Target intelligence / Profile preview

Cell surface proteins and membranes of recipient tissues

Molecular classification
Other, Cell surface proteins, Lipid bilayer
01

Overview

Cell surface proteins and membranes of recipient tissues refers to the complex biological interface comprising the lipid bilayer and the diverse array of proteins, glycoproteins, and glycolipids expressed on the exterior of cells within a target organ or tissue. This interface serves as the critical site for the initial interaction, binding, and internalization of various therapeutic modalities, including monoclonal antibodies, viral vectors, and lipid nanoparticles (PMID: 28811340). Biologically, these components are essential for maintaining cellular homeostasis, facilitating signal transduction, and mediating cell-cell recognition and adhesion (PMID: 31435460). In pathological contexts, such as viral infections or malignancy, these surfaces are often modified to facilitate pathogen entry or to evade host immune detection (PMID: 32296183). Because this term encompasses thousands of distinct molecular entities across diverse cell types, it is classified as a broad physiological compartment or site of action rather than a specific, individual therapeutic target. Consequently, drug discovery efforts typically focus on isolating specific receptors or transporters within this membrane rather than targeting the membrane as a collective unit.

Other names
Recipient cell surfaceHost cell plasma membraneTarget tissue interfaceCellular boundary
02

Mechanism of action

Interaction with the recipient cell surface via non-specific binding, ligand-receptor recognition, or membrane fusion to facilitate the delivery of therapeutic cargo or the initiation of intracellular signaling cascades.

03

Biological functions

Cell-cell communicationSignal transductionEndocytosisCellular adhesionBarrier function
04

Disease associations

InfectionCancerAutoimmune diseaseGraft-versus-host disease
05

Safety considerations

Off-target accumulation in non-recipient tissuesPotential for immunogenicity against surface-bound agentsDisruption of normal membrane integrity and homeostasis
06

Interacting drugs

Liposomal doxorubicin

2 more in the full profile.

07

Biomarkers

Cell surface marker expression (e.g., CD markers)Membrane fluidityReceptor density

Beyond the preview

Go deeper on Cell surface proteins and membranes of recipient tissues.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell surface proteins and membranes of recipient tissues.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call